You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

firmagon

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

FIRMAGON Intensive Drug Monitoring Protocol

Recruiting
  • Prostate Cancer
  • FIRMAGON Cohort
  • Beijing, China
    China Primary Healthcare Foundation
Dec 20, 2021

Metastatic Prostatic Adenocarcinoma Trial in Charleston (Docetaxel, Degarelix)

Active, not recruiting
  • Metastatic Prostatic Adenocarcinoma
  • Charleston, South Carolina
    Medical University of South Carolina
Jan 30, 2023

Invasive Ductal Breast Carcinoma Trial in Clamart (Degarelix injection(s))

Completed
  • Invasive Ductal Breast Carcinoma
  • Degarelix injection(s)
  • Clamart, France
    Hôpital Antoine Béclère
Sep 26, 2022

Prostate Cancer Trial in India (Degarelix)

Completed
  • Prostate Cancer
  • Bikaner, Rajasthan, India
  • +18 more
Dec 14, 2021

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,

Not yet recruiting
  • Localized Prostate Carcinoma
  • +3 more
  • Degarelix
  • MRI-guided transurethral ultrasound ablation (TULSA)
  • Turku, Southwest Finland, Finland
    Turku University Hospital
Jun 14, 2023

Prostate Adenocarcinoma Trial in France (Firmagon)

Recruiting
  • Prostate Adenocarcinoma
  • Firmagon
  • Clermont-Ferrand, France
  • +5 more
Mar 14, 2022

Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

Not yet recruiting
  • Metastatic Prostate Cancer
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Nov 14, 2022

Obesity, Fertility Trial in Aurora (Degarelix (GnRH antagonist), recombinant FSH, Cetrorelix)

Completed
Has Results
  • Obesity
  • Fertility
  • Degarelix (GnRH antagonist)
  • +2 more
  • Aurora, Colorado
    University of Colorado Clinical and Translational Research Cente
Mar 15, 2022

Endometriosis Trial in Tirana, Sofia, Rome (degarelix, goserelin)

Completed
  • Endometriosis
  • Tirana, Albania
  • +2 more
Feb 10, 2022

Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)

Active, not recruiting
  • Prostate Cancer
  • Los Angeles, California
    University of California, Los Angeles
Aug 25, 2022

Prostate Cancer Metastatic Trial in New York (REGN2810, Degarelix, Leuprolide Acetate)

Recruiting
  • Prostate Cancer Metastatic
  • New York, New York
    Columbia University Irving Medical Center
Mar 22, 2022

Cognitive Impairment, Estrogen Deficiency, Menopause Trial in Aurora, Boulder (GnRHant + E2, GnRHant + Placebo)

Completed
  • Cognitive Impairment
  • +4 more
  • GnRHant + E2
  • GnRHant + Placebo
  • Aurora, Colorado
  • +1 more
Jun 3, 2021

Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Prostate Cancer
  • Leuprolide acetate
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Stage IV Prostate Cancer Trial in Baltimore (procedure, drug, other, biological)

Completed
Has Results
  • Stage IV Prostate Cancer
  • Cryosurgery
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Nov 11, 2021

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)

Active, not recruiting
  • Prostate Adenocarcinoma
  • +4 more
  • Internal Radiation Therapy
  • +7 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 1, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)

Recruiting
  • Prostate Adenocarcinoma
  • Leuprolide Acetate
  • +5 more
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Treatment of Prostate Cancer With Firmagon®

Completed
  • Prostate Cancer
  • Planegg, Bavaria, Germany
    UCM GmbH
Apr 9, 2020

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Prostate Adenocarcinoma AJCC v7
  • +3 more
  • Abiraterone Acetate
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 15, 2021

Adenocarcinoma of Prostate Trial in France (Degarelix, Pelvic Radiotherapy)

Active, not recruiting
  • Adenocarcinoma of Prostate
  • Angers, France
  • +38 more
May 11, 2022

Prostate Cancer Recurrent Trial in Malmö (Degarelix 120 MG [Firmagon], Gonal F RFF Pen 900 UNT Per 1.5 ML Pen Injector,

Completed
  • Prostate Cancer Recurrent
  • Degarelix 120 MG [Firmagon]
  • +2 more
  • Malmö, Sweden
    Reproductive Medicine Center
Jan 21, 2020

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston

Withdrawn
  • Biochemically Recurrent Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2021

Prostatic Tumors Trial in London, Ottawa, Toronto (Degarelix)

Terminated
  • Prostatic Neoplasms
  • London, Ontario, Canada
  • +2 more
May 5, 2020